Given that Acute Mountain Sickness (AMS) effects 50 per cent of people who ascend to high altitude (altitudes of 2400m and above), research is constantly evolving to establish ways to prevent altitude sickness.

A new study from the University of Edinburgh published in the Plos One journal has found that AMS is not one illness with a range of symptoms – such as nausea, headaches and disrupted sleep – but more a collection of illnesses brought on by low oxygen environments, each with non-mutually exclusive symptoms.

Two groups were studied, comprised of sea-level dwellers acclimatised to high altitudes in Bolivia and around the Kilimanjaro area of Tanzania, Africa.

Subjects were asked to complete a visual analogue scale questionnaire, as well as the traditional Lake Louise Score (LLS) questionnaire, which includes assessment of headache, nausea, vomiting, fatigue/ weakness, dizziness and sleep quality.

Using a data analysis package, the results were evaluated to produce the first quantitative analysis of symptom correlation in altitude-related illnesses.

Results found that whilst headache, fatigue, nausea and dizziness all correlated with each other, sleep disturbance was an outlier and had only a secondary association with fatigue.

This will allow researches to isolate the symptoms of AMS, and start to build a strategy for discovering new ways to treating the symptoms of acute mountain sickness.

In the meantime, our ALTI-VIT capsules provide a unique formula of ingredients that support your ascents to high altitude.

Read more about ALTI-VIT, and purchase your own by clicking here.